GPHN - gephyrin Gene
Also Known as GPH; GEPH; HKPX1; GPHRYN; MOCODC
Species: Homo sapiens
About GPHN
This gene has 16 transcripts (splice variants), 243 orthologues and is associated with 91 phenotypes. Ubiquitous expression in kidney (RPKM 7.5), liver (RPKM 6.6) and 25 other tissues.
Summary
This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic Cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Products (8)
| mRNA | Protein | Name |
|---|---|---|
| NM_001024218.2 | NP_001019389.1 | gephyrin isoform 2 |
| NM_001377514.1 | NP_001364443.1 | gephyrin isoform 3 |
| NM_001377515.1 | NP_001364444.1 | gephyrin isoform 4 |
| NM_001377516.1 | NP_001364445.1 | gephyrin isoform 5 |
| NM_001377517.1 | NP_001364446.1 | gephyrin isoform 6 |
| NM_001377518.1 | NP_001364447.1 | gephyrin isoform 7 |
| NM_001377519.1 | NP_001364448.1 | gephyrin isoform 8 |
| NM_020806.5 | NP_065857.1 | gephyrin isoform 1 |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables identical protein binding |
IDA
IDA: Inferred from direct assay
|
25025157 | GOA |
| enables molybdopterin cofactor binding |
IDA
IDA: Inferred from direct assay
|
9990024 | GOA |
| enables nitrate reductase activity |
IMP
IMP: Inferred from mutant phenotype
|
9990024 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
21094642 | GOA |
| enables protein-macromolecule adaptor activity |
IMP
IMP: Inferred from mutant phenotype
|
25025157 | GOA |
| Biological Process GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| involved in gamma-aminobutyric acid receptor clustering |
IDA
IDA: Inferred from direct assay
|
26613940 | GOA |
| involved in gamma-aminobutyric acid receptor clustering |
IMP
IMP: Inferred from mutant phenotype
|
25025157 | GOA |
| involved in molybdopterin cofactor biosynthetic process |
IDA
IDA: Inferred from direct assay
|
26613940 | GOA |
| involved in molybdopterin cofactor biosynthetic process |
IMP
IMP: Inferred from mutant phenotype
|
9990024 | GOA |
| involved in response to metal ion |
IMP
IMP: Inferred from mutant phenotype
|
9990024 | GOA |
| Cellular Component GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| located in dendrite |
IDA
IDA: Inferred from direct assay
|
26613940 | GOA |
| is active in dendritic spine |
IDA
IDA: Inferred from direct assay
|
25025157 | GOA |
| is active in postsynaptic membrane |
IDA
IDA: Inferred from direct assay
|
25025157 | GOA |
| located in postsynaptic membrane |
IDA
IDA: Inferred from direct assay
|
26613940 | GOA |
| located in synaptic membrane |
IDA
IDA: Inferred from direct assay
|
25025157 | GOA |
GPHN Protein Structure
MoCF_biosynth: Probable molybdopterin binding domain (18 - 164)
MoeA_N: MoeA N-terminal region (domain I and II) (324 - 489)
MoCF_biosynth: Probable molybdopterin binding domain (502 - 645)
MoeA_C: MoeA C-terminal region (domain IV) (658 - 732)
- 0
- 200
- 400
- 600
- 736 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
gephyrin |
|
GPHN Antibodies
| Art. -Nr. | Produktname | Anwendung | Reactivity |
|---|---|---|---|
| HY-P82501 | Gephyrin Antibody (YA2246) | WB, IHC-P, ICC/IF | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Molybdenum Cofactor Deficiency, Complementation Group C |
|
|
| Arachnoid Cysts, Intracranial |
|
|
| Hyperekplexia 1 |
|
|
| Leber Congenital Amaurosis 13 |
|
|
| Anxiety |
|
|
| Glycosylphosphatidylinositol Biosynthesis Defect 17 |
|
|
| Retinal Dystrophy, Juvenile Cataracts, And Short Stature Syndrome |
|
|
| Hyperekplexia |
|
|
| Eye Disease |
|
|
| Cerebral Palsy |
|
|
| Leber Plus Disease |
|
|
| Cone-Rod Dystrophy 2 |
|
|
| Retinitis Pigmentosa |
|
|
| Fundus Dystrophy |
|
|
| Molybdenum Cofactor Deficiency |
|
|
| Stiff-Person Syndrome |
|
|
| Stargardt Disease |
|
|
| Stargardt Disease 1 |
|
|
| Sulfite Oxidase Deficiency, Isolated |
|
|
| Hyperekplexia 2 |
|
|
| Retinitis Pigmentosa 84 |
|
|
| Fragile X Syndrome |
|
|
| Molybdenum Cofactor Deficiency, Complementation Group A |
|
|
| Herpes Zoster Oticus |
|
|
| Molybdenum Cofactor Deficiency, Complementation Group B |
|
|
| Pervasive Developmental Disorder |
|
|
| Epilepsy |
|
|
| Glycine Encephalopathy |
|
|
| Epilepsy, Idiopathic Generalized |
|
|
| Epilepsy, Myoclonic Juvenile |
|
|
| Schizophrenia |
|
|
| Childhood Absence Epilepsy |
|
|
| Developmental And Epileptic Encephalopathy |
|
|
| Early Infantile Epileptic Encephalopathy |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | GPHN | MGD | MGI:109602 |
| Rattus norvegicus | GPHN | RGD | RGD:69194 |
| Canis familiaris | GPHN | VGNC | VGNC:41380 |
| Bos taurus | GPHN | VGNC | VGNC:54436 |
| Macaca mulatta | GPHN | VGNC | VGNC:72948 |
| Felis catus | GPHN | VGNC | VGNC:62666 |
| Others | GPHN | NCBI |